GH Stock Analysis: Buy, Sell, or Hold?
GH - Guardant Health, Inc. Common Stock
$161.99
9.64 (6.33%)
▲
5d:
+9.95%
30d:
-5.14%
90d:
+86.02%
BUY
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Jul 30, 2026
0d
Get Alerted When GH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: GH shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: GH shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: GH is currently trading at $161.99, which is considered slightly high relative to its 30-day fair value range of $142.49 to $163.15.
Technical Outlook: Technically, GH is in a strong uptrend. Immediate support is located at $140.86, while resistance sits at $176.58. The stock is showing strong short-term momentum, up 6.3% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, GH is in a strong uptrend. Immediate support is located at $140.86, while resistance sits at $176.58. The stock is showing strong short-term momentum, up 6.3% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$142.49 -
$163.15
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
66.8%
All Signals
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+6.3%)
- NEUTRAL: Near Wall St target ($173.17)
Trading Range Analysis
30-Day Trading Range
$142.49 -
$163.15
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$140.86
Resistance Level
$176.58
Current Trend
Strong Uptrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-400.47
Wall Street Target
$173.17
(+6.9%)
Revenue Growth (YoY)
48.3%
Profit Margin
-40.1%
Share & Embed Analysis
Last updated: August 02, 2026 6:12 PM ET
Data refreshes hourly during market hours. Next update: 7:12 PM
Data refreshes hourly during market hours. Next update: 7:12 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
5
Sells
Net
INSIDERS SELLING
Recent Transactions
Musa Tariq
SELL
116 shares
2026-04-16
Terilyn J Monroe
SELL
3832 shares
2026-04-06
Musa Tariq
SELL
348 shares
2026-03-18
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$630 | 53 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$228 | 52 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$283 | 59 HOLD |
|
IQV
IQVIA Holdings Inc |
BUY
23 analysts |
$273 | 64 BUY |
Advanced GH Option Strategies
Professional options setups generated by AI based on today's GH price and gamma walls.
